Your AI-Trained Oncology Knowledge Connection!
Commentary
Video
Author(s):
Comparing the UK & US Approaches to First-Line Treatment in Hodgkin Lymphoma
Wendy Osborne, MD, and Sarah Rutherford, MD, comparing the UK and US approaches to first-line treatment in Hodgkin lymphoma.
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 6th 2025 - Jul 12th 2025
Jun 6th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 6th 2025 - Jul 12th 2025
Jun 6th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Jun 5th 2025 - Jul 12th 2025
Anito-Cel Drives Durable Responses in R/R Multiple Myeloma
IRAKLIA Data Support Subcutaneous Isatuximab as a SOC Administration Approach in Myeloma
Addition of Dasatinib to Induction/Consolidation Fails to Boost Survival in Core-Binding Factor AML
Talquetamab/Cetrelimab Leads to Deep, Durable Responses in R/R Multiple Myeloma
2 Commerce Drive
Cranbury, NJ 08512